Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson’s disease: a behavioral and neurochemical study in reserpinized mice-Reference-Cited by-同舟云学术

Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson’s disease: a behavioral and neurochemical study in reserpinized mice

Published:2010-11-11 Issue:6 Volume:115 Page:1543-1555
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Volta Mattia,Mabrouk Omar S.,Bido Simone,Marti Matteo,Morari Michele

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2010.07061.x/fullpdf

Reference49 articles.

1. Animal models of Parkinson’s disease;Betarbet;Bioessays,2002

2. Dopamine and glutamate control each other’s release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra;Biggs;Neurosci. Biobehav. Rev.,1997

3. Differential protection against MPTP or metamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression;Brown;J. Neurochem.,2006

4. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists;Carlsson;Nature,1957

5. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism;Cole;Neuroscience,1994

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?;International Journal of Molecular Sciences;2023-01-13

2. Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification;European Journal of Medicinal Chemistry;2022-07

3. Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders;Neuropeptides;2020-08

4. Discovery and Structure–Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models;Journal of Medicinal Chemistry;2020-01-17

5. Managing Parkinson's disease: moving ON with NOP;British Journal of Pharmacology;2020-01